Skip to main content
. 2014 Mar 13;2014:565784. doi: 10.1155/2014/565784

Table 3.

The upregulated and downregulated genes after the treatment of HLJDD.

Gene Abbr. Gene Id Chro. FC P
Solute carrier family 4 (anion exchanger), member 1 Slc4a1 24779 10 3.871 6.74E − 03
Protein phosphatase 1, regulatory subunit 3D Ppp1r3d 689995 3 2.566 2.78E − 03
Ribonucleotide reductase M2 Rrm2 362720 6 2.551 6.30E − 03
pim-1 oncogene Pim1 24649 20 2.529 5.12E − 03
Spectrin, beta, erythrocytic Sptb 314251 6 2.470 4.66E − 03
Transmembrane and coiled-coil domain family 2 Tmcc2 305095 13 2.444 3.38E − 03
Unknown NA 3 2.264 7.87E − 03
UI-R-C4-alc-g-09-0-UI NA Un 0.235 3.60E − 03
UI-R-BJ2-bql-b-07-0-UI NA 13 0.385 3.14E − 03
Potassium voltage-gated channel, subfamily H (eag-related), member 1 Kcnh1 65198 13 0.393 9.98E − 03
Nuclear receptor subfamily 4 group A member 3 Nr4a3 58853 5 0.456 9.87E − 03

Note. Abbr.: gene abbreviation, Chro.: chromosome, Gene Id represents the identity (ID) of the gene in GenBank; FC = HLJDT treatment group/SHR model group gene expression level. “—/NA/Un” indicates unknown.